Temporal profile of molecular signatures associated with circulating endothelial progenitor cells in human ischemic stroke.
about
Endothelial progenitor cells in ischemic stroke: an exploration from hypothesis to therapyVascular endothelial growth factors (VEGFs) and strokeStem cell recruitment of newly formed host cells via a successful seduction? Filling the gap between neurogenic niche and injured brain siteCirculating CD133+ CD34+ progenitor cells and plasma stromal-derived factor-1alpha: predictive role in ischemic stroke patients.Stem cell-paved biobridge facilitates neural repair in traumatic brain injury.A possible new focus for stroke treatment - migrating stem cellsStem Cell-Induced Biobridges as Possible Tools to Aid Neuroreconstruction after CNS Injury.Increased Endothelial Progenitor Cell Levels are Associated with Good Outcome in Intracerebral Hemorrhage.Endothelial progenitor cells in acute ischemic stroke.Accelerating in situ endothelialisation of cardiovascular bypass grafts.Stem cell-paved biobridges facilitate stem transplant and host brain cell interactions for stroke therapy.Synergic effects of VEGF-A and SDF-1 on the angiogenic properties of endothelial progenitor cells.Preconditioning-induced CXCL12 upregulation minimizes leukocyte infiltration after stroke in ischemia-tolerant mice.Decreased levels of angiogenic growth factors in intracranial atherosclerotic disease despite severity-related increase in endothelial progenitor cell counts.Imaging angiogenesis using 68Ga-NOTA-PRGD2 positron emission tomography/computed tomography in patients with severe intracranial atherosclerotic disease.Changes in serum vascular endothelial growth factor and endostatin concentrations associated with circulating endothelial progenitor cells after acute ischemic stroke.Effects of Angiotensin-Converting Enzyme Inhibition on Circulating Endothelial Progenitor Cells in Patients with Acute Ischemic Stroke.Exogenous stem cells pioneer a biobridge to the advantage of host brain cells following stroke: New insights for clinical applications
P2860
Q26823609-9C6F611D-C387-41AB-A871-14D015640CF2Q26853592-0B71BD49-6B28-4237-B4E2-FB99ED24AEABQ27306345-183FA8F5-8158-46BB-86DE-3DED94B4D396Q30392417-3C1FD824-3742-4FA3-9BD9-E19DE39C9C51Q35204205-C80D4BD7-A3EB-4956-9D21-362C28A2CC7CQ35738018-16C80F0C-5FFC-4D3E-8EE1-C4F4457EC257Q36379561-77D41734-8371-4557-AE6F-C1A861FC1361Q37039953-DE35F01A-9FFC-4755-B526-EE755D0AC0C3Q37403696-F510BCEC-C9A9-4AB8-A77B-845E1D120AB0Q38304670-69706551-A3BF-4ACD-B713-25D790A6269DQ38377637-7595527E-E4BB-49E8-B2F7-F005D704CB6FQ39108577-2DFC7B2A-A658-4D73-A8BA-14EAF45DF0BEQ39896010-70FE292A-1BB1-4298-99A9-92DD3E8BBC9DQ44893714-2B9FD266-5BA4-4E48-B7AB-3C02BCFCC6DCQ48273386-97DA58DE-07AA-4662-90AF-AFED393B3676Q48347982-45BD7117-9848-4232-AE1E-ACC6488DA51FQ55397012-79F987DE-1C12-4D6B-AFB9-04FF39016F81Q57153054-99B311A3-80EE-442C-BFA3-C5B67A64B481
P2860
Temporal profile of molecular signatures associated with circulating endothelial progenitor cells in human ischemic stroke.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Temporal profile of molecular ...... ells in human ischemic stroke.
@en
Temporal profile of molecular ...... ells in human ischemic stroke.
@nl
type
label
Temporal profile of molecular ...... ells in human ischemic stroke.
@en
Temporal profile of molecular ...... ells in human ischemic stroke.
@nl
prefLabel
Temporal profile of molecular ...... ells in human ischemic stroke.
@en
Temporal profile of molecular ...... ells in human ischemic stroke.
@nl
P2093
P2860
P356
P1476
Temporal profile of molecular ...... ells in human ischemic stroke.
@en
P2093
David Brea
Manuel Rodríguez-Yáñez
María Pérez-Mato
Miguel Blanco
P2860
P304
P356
10.1002/JNR.23068
P577
2012-04-19T00:00:00Z